Archive by date | November 8th, 2012

Unlocking the Molecular Diagnostic Interpretation Bottleneck

Unlocking the Molecular Diagnostic Interpretation Bottleneck

As noted in the news feature Direct-to-consumer genomics reinvents itself, 23andMe has filed to secure 510(k) clearance for some of its genetic tests, which poses the question of whether a foot in the door at the FDA will increase demand and re-energize the direct to consumer (DTC) genomics market?  Read more